In the leukemia model, cancer cell-secreted factors such as VEGF activate ECs in a paracrine fashion to support leukemia expansion by releasing leukemic cell trophogens or by increasing leukemic cell survival through HSP90-mediated induction of Bcl-2 expression and apoptosis inhibition [30–32]. The gene discussed is BCL2; the disease is leukemia.